Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10896915 | Cancer Detection and Prevention | 2005 | 8 Pages |
Abstract
Objective: Lysosomal cysteine cathepsins have been implicated in tumor progression. This study is aimed to reveal differential expression and compare the prognostic significance of cathepsins B and L in glioma patients. Methods: The histological slides of 82 patients with primary astrocytic tumors were reviewed. We evaluated the immunostaining of the cathepsins in tumor and endothelial cells. Results: Cathepsins B and L stained positive in 98 and 88% of cases, respectively. The total score was significantly higher in malignant than in benign tumors, both for cathepsin B (p < 0.001) and for cathepsin L (p < 0.01). The IHC score in endothelial cells in the malignant group was significantly higher only for cathepsin B (p < 0.0001). Survival analysis indicated that in contrast to the prognostic significance of total cathepsin B and endothelial cells associated cathepsin B for shorter patients' survival, the prognostic role of cathepsin L was not confirmed. Conclusion: Cathepsin L is preferentially expressed in tumor cells, increasing with glioma progression, but is not significantly associated with new vasculature of glioblastoma. In contrast to cathepsin B, cathepsin L has no prognostic impact, suggesting different roles of the two cathepsins in glioma progression.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Tadej MD, PhD, Rajko MD, MSc, Miha MD, MSc, Tamara T. PhD,